A microRNA gene expression signature predicts response to erlotinib in epithelial cancer cell lines and targets EMT

BACKGROUND: Treatment with epidermal growth factor receptor (EGFR) inhibitors can result in clinical response in non-small-cell lung cancer (NSCLC) and pancreatic ductal adenocarcinoma (PDAC) for some unselected patients. EGFR and KRAS mutation status, amplification of EGFR, or gene expression predi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bryant, J L, Britson, J, Balko, J M, Willian, M, Timmons, R, Frolov, A, Black, E P
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2012
Assuntos:
Molecular Diagnostics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3251842/
https://ncbi.nlm.nih.gov/pubmed/22045191
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2011.465
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados